Latest News Newsletter Archive

Cellectricon presents a webinar with real-life examples on 16 May, 11am-12pm (EDT)

Mölndal, Sweden, April. 29, 2013

Cellectricon, a leading provider of advanced cell-based screening technologies and services, invites researchers to join a webinar investigating new methods for approaching drug development in the fields of CNS and chronic pain.

Mölndal, Sweden, April. 23, 2013

Cellectricon is excited to announce the release of its first newsletter. Containing insightful information about the launch of our new Discovery Services, including the capabilities of our revolutionary technology and an interview with Dr Paul Karila (Head of Discovery Services), the newsletter is an ideal way to keep up-to-date with all our news and events.

Mölndal, Sweden, April. 17, 2013

Cellectricon, a leading provider of advanced cell-based screening technologies and services, will be exhibiting its revolutionary in-situ transfection technology platforms on booth #1178 at the Experimental Biology conference (20-24 April, Boston, US).

Mölndal, Sweden, April. 4, 2013

Cellectricon today announced the launch of its Discovery Services division. The new services offer pharma/biotech companies and CROs cutting-edge phenotypic screening support, accelerating drug discovery and cell-based assay research into cytoskeletal disturbances – especially for chronic pain.

Mölndal, Sweden, March. 4, 2013

Cellectricon announced today that it has expanded its sales and service network into Asia. The company signed a distribution agreement for its Dynaflow® line with Japan-based Novel Science Co., Ltd. In addition, Nepa Gene Co., Ltd., will distribute Cellectricon’s Cellaxess®ACE system and module in Japan.